Compare UMC & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UMC | HOLX |
|---|---|---|
| Founded | 1980 | 1985 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical Electronics |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.0B | 16.6B |
| IPO Year | 2000 | 1990 |
| Metric | UMC | HOLX |
|---|---|---|
| Price | $7.84 | $75.06 |
| Analyst Decision | Strong Sell | Hold |
| Analyst Count | 1 | 15 |
| Target Price | N/A | ★ $79.64 |
| AVG Volume (30 Days) | ★ 8.3M | 3.1M |
| Earning Date | 01-20-2026 | 11-03-2025 |
| Dividend Yield | ★ 4.74% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.10 | ★ 2.49 |
| Revenue | ★ $7,746,022,974.00 | $4,100,500,000.00 |
| Revenue This Year | $3.20 | $6.69 |
| Revenue Next Year | $6.45 | $5.74 |
| P/E Ratio | ★ $14.41 | $30.13 |
| Revenue Growth | ★ 4.08 | 1.74 |
| 52 Week Low | $5.61 | $51.90 |
| 52 Week High | $8.33 | $80.31 |
| Indicator | UMC | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 62.54 | 70.96 |
| Support Level | $7.15 | $74.09 |
| Resistance Level | $7.45 | $75.06 |
| Average True Range (ATR) | 0.17 | 0.26 |
| MACD | 0.06 | -0.14 |
| Stochastic Oscillator | 94.44 | 91.58 |
Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 5% market share in 2024 after TSMC and SMIC. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the us, and South Korea. UMC features a diverse customer base that includes Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx, and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.